Drawing for PHARMAVENTURES

USPTO serial 86455967

PHARMAVENTURES

Reviewed by CopyMark Law Group

Reg. 4772557Status 800Registered
Filing date
Status date
Registration date
Jul 14, 2015
Examiner
BRODY, DANIEL S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with PHARMAVENTURES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laurence P. Colton

Laurence P. Colton SMITH TEMPEL BLAHA LLC1600 Parkwood Circle SE, Suite 620ATLANTA, GA 30339United States

Goods and services

ClassDescriptionStatusFirst use
035Advertising, marketing and promotion services in the field of concepts, products, supplements and preparations related to medication, dietetic products medicated and non-medicated additives for foodstuffs and beverages, and diagnostic products; Business acquisition and merger consultation; Business advisory services in the field of pharmaceutical, healthcare research, medicated and non-medicated food and beverage and dietary supplements industries, and product licensing and transfer services for other of pharmaceutical drugs, medical devices, drug delivery devices, and diagnostics and platform technologies that accelerate drug discovery and development; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services in the field of pharmaceutical, healthcare research, medicated and non-medicated food and beverage and dietary supplements industries, and product licensing and transfer services for other of pharmaceutical drugs, medical devices, drug delivery devices, and diagnostics and platform technologies that accelerate drug discovery and development; Business research services in the field of healthcare research and development of pharmaceuticals and dietary preparations, substances, and supplements performed for others; business consulting services in the field of assisting others in obtaining clinical trial and research services in the fields of pharmaceuticals and biotechnology; Business strategy development services; Consulting services in the field of managing intellectual properties; Consulting services in the field of medical product approval for commercial purposes; Expert evaluations and reports relating to business matters; Market research servicesACTIVENov 30, 1997
036Intellectual property valuation servicesACTIVENov 30, 1997
042Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fieldsACTIVENov 30, 1997
045Consulting in the field of intellectual property licensingACTIVENov 30, 1997

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 23, 2025NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Sep 23, 2025RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Sep 23, 202589AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Sep 22, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 30, 2025E89RTEAS SECTION 8 & 9 RECEIVED—
Jul 14, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Oct 1, 2021NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 1, 2021C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 1, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 18, 2021E815TEAS SECTION 8 & 15 RECEIVED—
Jul 14, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 14, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 28, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 28, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2015DOCKASSIGNED TO EXAMINER—
Apr 8, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 21, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 21, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 17, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Mar 17, 2015ALIEASSIGNED TO LIE—
Mar 17, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 17, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 17, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 7, 2015DOCKASSIGNED TO EXAMINER—
Nov 22, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance